Hired and Retired: Management moves in a time of crisis
As the pandemic continues to rumble on, biopharma companies have been reshuffling the pack on their executive boards.
The month of March saw the coronavirus sweep the globe, as a number of biopharma companies were looking to consolidate leadership positions for the coming year and beyond.
In one particular case, this saw the CEO position change hands no fewer than three times in the space of just a few weeks, with various rumors swirling regarding the possible cause.
Elsewhere, there were more straight forward leadership changes for Fujifilm Diosynth and Genmab. Click through the gallery to find out more about other leadership changes across the industry.